References
- Adams JE 3rd, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation. 1993;88:750–763.
- Adams JE III, Bodor GS, Davila-Roman VG, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 1993; 88:101–146.
- Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 1995;41:1710–1715.
- Ricchiuti V Voss EM, Ney A, Ödland M, Anderson PA, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim.. Clin Chem. 1998;44:1919–1924.
- Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined – A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36: 959–969.
- Jaffe AS, Ravkilde J, Roberts R, et al. It’s time for a change to a troponin standard. Circulation. 2000;102:1216–1220.
- Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Available at: www.acc.org/qualityandscience/clinical/statements.htm. Accessed August 24, 2006.
- Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (W riting Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, American College or Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2007;50:e1. Available at: www.acc.org/qualityandscience/clinical/ statements.htm. Accessed September 18, 2007.
- Lum G, Solarz DE, Farney F. MT(ASCP) False positive cardiac troponin results in patients without acute myocardial infarction. Lab Med. 2006;37:546–550.
- Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: Incidence and clinical significance. Chest. 2004;125:1877–1884.
- Higgins JP, Higgins JA. Elevation of cardiac troponin I indicates more than myocardial ischemia. Clin Invest Med. 2003;26:133–147.
- Jeremias A, Gibson CM. Narrative review: Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005;142:786–792.
- Wittstein IS, Thiemann DR, Lima JAC, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539–548.
- Öffice of In Vitro Diagnostic Device Evaulation and Safety. Safety tips for laboratorians. Available at: www.fda.gov/cdrh/labsafetytips.html. Accessed May 26, 2005.
- Myocardial infarction redefined – A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502–1513.
- Kaplan IV, Levinson SS. When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen. Clin Chem. 1999;45:616–618.
- Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999;45:942–956.
- Kricka LJ, Schmerfeld-Pruss D, Senior M, et al. Intereference by human anti-mouse antibody in two-site immunoassays. Clin Chem. 1999;36:892–894.
- Boscato KM, Stuart MC. Incidence and specificity of interference in two-site immunoassays. Clin Chem. 1986;32:1491–1495.